The Future of Cancer Biomarkers: What's in the Pipeline - Samir Hanash, MD, PhD

Substantial progress has been made in our understanding of the molecular basis of cancer, yet few diagnostics have been developed to date. Opportunities and challenges in developing blood based molecular diagnostics are reviewed from a lung cancer perspective by Dr. Samir Hanash, of the Fred Hutchinson Cancer Research Center. The contribution of DNA, RNA, proteins, metabolites and circulating tumor cells to lung cancer diagnostics are presented. Samir Hanash MD, PhD, program head, Molecular Diagnostics, Fr